Stock·NYSE·Real Estate
Vivmark Residential (VMRK)
- Market cap
- $47.32B
- P/E
- 23.67
- Dividend yield
- 4.58%
- Street target
- $73.00median of 21 analysts
- 52-week range
- $57.57 $71.50
The short version
Where VMRK stands today, in four lines, and what CleaRank Financial AI makes of it.
VMRK at a glance
Vivmark Residential (VMRK): Hold, 55/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($63.63 and $63.99).
- Insiders Insiders sold $4.7M and made no open-market purchases over the last 18 months.
- Valuation P/E of 23.7 against 44.7 for the Real Estate sector: a discount to peers (-47%).
Figures as of October 15, 2026.
CleaRank Financial AI
Vivmark Residential (VMRK) is currently trading at $61.15, below its 50-day SMA of $63.63 and 200-day SMA of $63.99, indicating a bearish short-term technical trend.
The company operates in the Residential REIT sector, which has a median P/E of 44.7 and revenue growth of 11.0%, while VMRK's P/E is 23.67 and its revenue growth is 3.3%. Analysts maintain a 'Buy' consensus with a median price target of $73.00, suggesting an upside of 19.4% from the current price. However, insider transactions show a net seller position with $4.7 million in sales versus no purchases, signaling moderate insider selling pressure. The company's fundamentals show a profit margin of 33.25% and a debt-to-equity ratio of 0.75, which is in line with the sector median. The current price action, coupled with insider selling, presents a risk despite the analyst optimism. Investors should monitor upcoming earnings reports and any shifts in insider activity for further directional clues.
Only on CleaRank
Figures we compute ourselves from VMRK's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $61.15 is 3.9% below the 50-day simple moving average of $63.63.Price above its 200-day average ›
The price is 4.4% below the 200-day simple moving average of $63.99.50-day average above the 200-day ›
The 50-day average ($63.63) is 0.6% below the 200-day average ($63.99), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 26% of its 52-week range, between $57.57 and $71.50.
VMRK share price
Pick a period: each tab shows how far VMRK has moved over it, to the last close.
Today's trading
Where VMRK sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 23.67 is 47.0% below the Real Estate median of 44.7.P/S below the sector median ›
The price-to-sales ratio of 15.35 is 47.6% above the sector median of 10.4.Profitable over the last 12 months ›
Net income over the last 12 months was $1.0B on revenue of $3.1B, a net margin of 33.3%.Pays a dividend ›
The trailing dividend yield is 4.58%, or $2.80 a share a year.
Key statistics
The headline figures for VMRK.
As of October 15, 2026, VMRK trades at $61.15, with a market value of $47.32B, a P/E ratio of 23.67 and a dividend yield of 4.58%.
What the numbers say
CleaRank Financial AI's reading of VMRK's valuation, growth and risks.
Vivmark Residential (VMRK) trades at a P/E ratio of 23.67, which is below the sector median of 44.7, suggesting a potential valuation discount relative to peers.
The company reports a profit margin of 33.25% and an operating margin of 29.50%, significantly higher than the sector median ROE of 5.8%. Its debt-to-equity ratio is 0.75, which is in line with the sector average. While the valuation appears attractive on a P/E basis, the high P/S ratio compared to the sector median requires closer examination. The strong profit margins and reasonable debt levels provide a stable fundamental base.
VMRK against the Real Estate sector
How VMRK compares with the median Real Estate stock CleaRank tracks.
Price to earnings vs sector: VMRK trades at a notable discount to sector peers (-47%), which may indicate undervaluation or specific company headwinds.
Return vs XLRE: Since May 5, 2025, VMRK has lost 13.7% against a gain of 0.1% for XLRE.
Performance against XLRE
VMRK and the Real Estate sector fund over the same days.
Revenue and earnings
How much VMRK sells, and how much of it becomes profit.
Profitable: VMRK earned $1.1B in FY2025.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 45.0, in neutral territory.RSI above 50 ›
An RSI of 45.0 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of VMRK
The score, the reasoning behind it, and what could move the price next.
Vivmark Residential's stock is trading below its 50-day SMA ($63.63) and 200-day SMA ($63.99), indicating a bearish trend.
The 20-day EMA at $61.38 also sits above the current price, reinforcing the short-term downward pressure. The 14-day RSI is at 45.02, reflecting neutral momentum, while the CCI is at 79.87, suggesting some positive sentiment but not extreme overbought conditions. The current price of $61.15 is testing recent lows. The overall technical picture is mixed, with bearish positioning relative to longer-term averages tempered by neutral RSI momentum.
Projected Strong Revenue Growth ›
Analysts forecast Vivmark Residential (VMRK) to achieve 49.00% revenue growth in the next year, reaching an estimated $6.5 billion, which could drive future performance.
Source: Wall Street Revenue EstimatesTrading Below Key Moving Averages ›
Vivmark Residential (VMRK) is currently trading below its 50-day SMA ($63.63) and 200-day SMA ($63.99), indicating a bearish technical trend that may require a catalyst to reverse.
Source: Technical Analysis
Moderate Insider Selling Pressure ›
Insiders have sold $4.7 million worth of Vivmark Residential (VMRK) stock with no reported purchases, indicating a lack of strong insider conviction and potentially signaling caution.
Source: Insider Transactions
- Vivmark Residential (VMRK) is trading below its 50-day and 200-day moving averages ($63.63 and $63.99), suggesting a bearish technical setup that may limit near-term upside potential.
Technical indicators
Momentum and trend for VMRK, from its daily closes.
As of October 15, 2026, with VMRK at $61.15, its 14-day RSI is 45.0 (neutral territory), its 50-day simple moving average is $63.63 and its 200-day is $63.99.
Calculated by CleaRank on daily closes as of October 15, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What VMRK moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 15, 2026, VMRK's 1-year correlation of daily returns is +0.38 with S&P 500 (SPY), +0.21 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.05 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
10 of 21 analysts rate it a buy or strong buy, 11 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $73.00 is 19.4% above the price.More buy ratings than three months ago ›
10 of 21 rate it a buy now, against 5 of 20 three months ago.
VMRK Wall Street View
12-month price targets
The price, $61.15, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Piper Sandler | Maintains | Neutral |
| Sep 21, 2026 | Evercore ISI Group | Maintains | In-Line |
| Sep 17, 2026 | Scotiabank | Maintains | Sector Perform |
| Sep 17, 2026 | BTIG | Reiterates | Neutral |
| Sep 15, 2026 | UBS | Initiates | Buy |
| Sep 8, 2026 | Mizuho | Upgrade | Outperform |
As of October 15, 2026, 21 Wall Street analysts cover VMRK: 10 rate it a buy or strong buy, 11 a hold and 0 a sell or strong sell. Their 12-month price targets range from $63.00 to $80.00, with a median of $73.00, 19.4% above the price of $61.15.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
VMRK trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from VMRK's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much VMRK tends to move, against the market and on its own.
The long record
VMRK's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.31% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 45.8%, from October 2019 to October 2020, regained by July 2021.Most 1-year holds ended higher ›
56% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $14,266, against $42,405 in the S&P 500 (SPY).
VMRK Drawdowns & Recovery
As of October 15, 2026, VMRK's worst peak-to-trough fall over the last 10 years with dividends reinvested was -45.8% (October 2019 to October 2020); it regained that peak by July 2021, 9 months after the low, and 56% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into VMRK in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: VMRK trailed the S&P 500 over this period: $14,266 against $42,405.
A $10,000 investment in VMRK in October 2016 would be worth about $14,266 today with dividends reinvested, compared with about $42,405 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to VMRK, and which have not.
Strongest month, April: an average of +4.26%, up in 7 of 10 years.
Weakest month, September: an average of -3.65%, up in 3 of 10 years.
This month, October: has averaged -1.46%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, VMRK's strongest calendar month has been April (average +4.26%, up in 7 of 10 years) and its weakest September (average -3.65%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in VMRK, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in VMRK today could grow to about $13,539 by 2036 in the base case, with a 90th-percentile outcome near $37,534 and a 10th-percentile outcome around $4,884. The simulation models price only; at today's 4.58% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
VMRK Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $69.03 for VMRK by 2030 in the base case, from $61.15 today (1.1x over 4 years). The 10th-percentile path ends near $36.22. These are outcomes of a Monte Carlo simulation run on VMRK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $45.66 | $63.03 | $87.01 | |
| 2028 | $41.18 | $64.97 | $103 | |
| 2029 | $38.31 | $66.97 | $117 | |
| 2030 | $36.22 | $69.03 | $132 | |
| 2031 | $34.60 | $71.15 | $146 |
Method: a lognormal simulation of VMRK's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
VMRK insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought VMRK shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 15, 2026, VMRK insiders reported 15 open-market sales worth $4.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Chris Carr
Director
|
Sell | 1.1K | $73.8K |
| Aug 31, 2026 | Scott J. Fenster
General Counsel
|
Grant | 4.6K | - |
| Aug 31, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 34.6K | - |
| Aug 21, 2026 | Sean Thomas Willson
Officer
|
Sell | 300 | $19.9K |
| Aug 20, 2026 | Matthew H Birenbaum
Officer
|
Grant | 1.4K | - |
| Aug 19, 2026 | Sean Thomas Willson
Officer
|
Sell | 250 | $16.1K |
| Aug 18, 2026 | Edward M Schulman
Officer
|
Sell | 16.6K | $1.1M |
| Aug 18, 2026 | Susan Swanezy
Director
|
Sell | 15.7K | $1.0M |
| Aug 18, 2026 | Christopher Howard
Director
|
Sell | 8.5K | $543.1K |
| Aug 18, 2026 | Charles E. Mueller Jr.
Director
|
Sell | 8.0K | $511.2K |
| Aug 17, 2026 | Michael L Manelis
Chief Operating Officer
|
Sell | 7.8K | $503.2K |
| Aug 17, 2026 | Matthew H Birenbaum
Officer
|
Grant | 35.9K | - |
| Aug 17, 2026 | Chris Carr
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Mary Kay Haben
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Ann C. Hoff
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Nina P. Jones
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 8.8K | - |
| Aug 17, 2026 | Timothy James Naughton
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Stephen E Sterrett
Chairman of the Board
|
Grant | 2.6K | - |
| Aug 17, 2026 | Pamela Rogers Thomas
Officer
|
Grant | 56.7K | - |
| Aug 17, 2026 | Sean Thomas Willson
Officer
|
Grant | 6.0K | - |
| Aug 14, 2026 | Ian Kaufman
Officer
|
Grant | 30 | $1.7K |
| Jun 18, 2026 | Mary Kay Haben
Director
|
Grant | 3.3K | - |
| Jun 18, 2026 | Ann C. Hoff
Director
|
Grant | 3.3K | - |
| Jun 18, 2026 | Nina P. Jones
Director
|
Grant | 3.3K | - |
| Jun 18, 2026 | Stephen E Sterrett
Director
|
Grant | 3.3K | - |
| May 14, 2026 | Ian Kaufman
Officer
|
Grant | 32 | $1.7K |
| Mar 2, 2026 | Ian Kaufman
Officer
|
Grant | 150 | $7.9K |
| Feb 18, 2026 | Michael L Manelis
Chief Operating Officer
|
Sell | 2.4K | $154.4K |
| Feb 18, 2026 | Ian Kaufman
Officer
|
Sell | 909 | $57.8K |
| Feb 18, 2026 | Catherine Carraway
Officer
|
Sell | 749 | $47.6K |
| Feb 10, 2026 | Michael L Manelis
Chief Operating Officer
|
Sell | 5.8K | $375.5K |
| Feb 10, 2026 | Robert A Garechana
Chief Investment Officer
|
Sell | 3.6K | $236.9K |
| Feb 10, 2026 | Catherine Carraway
Officer
|
Sell | 656 | $42.7K |
| Feb 9, 2026 | Catherine Carraway
Officer
|
Grant | 4.8K | - |
| Feb 9, 2026 | Scott J. Fenster
General Counsel
|
Grant | 9.2K | - |
| Feb 9, 2026 | Ian Kaufman
Officer
|
Grant | 4.6K | - |
| Feb 9, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 12.0K | - |
| Feb 9, 2026 | Bret D. Mcleod
Chief Financial Officer
|
Grant | 6.8K | - |
| Feb 9, 2026 | Mark J Parrell
Chief Executive Officer
|
Grant | 19.9K | - |
| Jan 16, 2026 | Catherine Carraway
Officer
|
Grant | 3.0K | - |
| Jan 16, 2026 | Robert A Garechana
Chief Investment Officer
|
Grant | 11.0K | - |
| Jan 16, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 13.1K | - |
| Dec 30, 2025 | David J Neithercut
Chairman of the Board
|
Grant | 42.5K | - |
| Nov 14, 2025 | Ian Kaufman
Officer
|
Grant | 39 | $2.0K |
| Aug 14, 2025 | Ian Kaufman
Officer
|
Grant | 37 | $2.0K |
| Aug 14, 2025 | Stephen E Sterrett
Director
|
Grant | 1.9K | $100.0K |
| Aug 7, 2025 | Chris Carr
Director
|
Grant | 3.0K | - |
| Aug 7, 2025 | Bret D. Mcleod
Chief Financial Officer
|
Grant | 19.6K | - |
| Jul 1, 2025 | Linda Walker Bynoe
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Mary Kay Haben
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Ann C. Hoff
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Nina P. Jones
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Stephen E Sterrett
Director
|
Grant | 3.1K | - |
| May 14, 2025 | Ian Kaufman
Officer
|
Grant | 24 | $1.4K |
| May 1, 2025 | Catherine Carraway
Officer
|
Sell | 1.0K | $71.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 15, 2026.